Conferences

ecancer travels so that you don't have to. Expore the latest conference coverage in global oncology and find out where we are going next.
Bookmark and Share

EBCC 8

21 - 24 Mar 2012
Spetses, Greece
Pregnancy following oestrogen receptor-positive breast cancer is safe
Dr Hatem A. Azim - Institut Jules Bordet, Brussels, Belgium
Pregnancy following oestrogen receptor-positive breast cancer is safe ( Dr Hatem A. Azim - Institut Jules Bordet, Brussels, Belgium )
12 Apr 2012
European Breast Cancer Conference - success and future
Prof Michael Gnant - Medical University of Vienna, Austria
European Breast Cancer Conference - success and future ( Prof Michael Gnant - Medical University of Vienna, Austria )
4 Apr 2012
Advocating for metastatic breast cancer patients
Susan Knox - Executive Director, Europa Donna
Advocating for metastatic breast cancer patients ( Susan Knox - Executive Director, Europa Donna )
4 Apr 2012
Mouse models of metastatic breast cancer
Prof Jos Jonkers - Netherlands Cancer Institute, Amsterdam
Mouse models of metastatic breast cancer ( Prof Jos Jonkers - Netherlands Cancer Institute, Amsterdam )
4 Apr 2012
Advanced breast cancer consensus and the latest on triple negative breast cancer
Prof Eric Winer - Dana-Farber Cancer Institute, Boston, USA
Advanced breast cancer consensus and the latest on triple negative breast cancer ( Prof Eric Winer - Dana-Farber Cancer Institute, Boston, USA )
4 Apr 2012
Cancer survivorship: NCI research and insights
Dr Julia Rowland - Office of Cancer Survivorship, NCI, USA
Cancer survivorship: NCI research and insights ( Dr Julia Rowland - Office of Cancer Survivorship, NCI, USA )
4 Apr 2012
A pregnancy pill to prevent breast cancer?
Prof Valerie Beral - University of Oxford
A pregnancy pill to prevent breast cancer? ( Prof Valerie Beral - University of Oxford )
4 Apr 2012
Chemothereapy with endocrine therapy and bisphosphonates in early breast cancer
Prof Michael Gnant - Medical University of Vienna, Austria
Chemothereapy with endocrine therapy and bisphosphonates in early breast cancer ( Prof Michael Gnant - Medical University of Vienna, Austria )
2 Apr 2012
Anti-HER2 treatment in metastatic breast cancer: trastuzumab and beyond
Dr Evandro De Azambuja - Institut Jules Bordet, Brussels, Belgium
Anti-HER2 treatment in metastatic breast cancer: trastuzumab and beyond ( Dr Evandro De Azambuja - Institut Jules Bordet, Brussels, Belgium )
2 Apr 2012
Results of seven year intraoperative radiation therapy trial
Prof Roberto Orrechia - European Institute of Oncology, Milan, Italy
Results of seven year intraoperative radiation therapy trial ( Prof Roberto Orrechia - European Institute of Oncology, Milan, Italy )
2 Apr 2012
Endocrine management of breast cancer and advanced breast cancer
Prof Stephen Johnston - Royal Marsden Hospital, London, UK
Endocrine management of breast cancer and advanced breast cancer ( Prof Stephen Johnston - Royal Marsden Hospital, London, UK )
2 Apr 2012
Non-drug treatments to help alleviate symptoms of treatment-induced menopause
Dr Marc van Beurden - Netherlands Cancer Institute, Amsterdam
Non-drug treatments to help alleviate symptoms of treatment-induced menopause ( Dr Marc van Beurden - Netherlands Cancer Institute, Amsterdam )
2 Apr 2012
15-year follow-up on radiotherapy treatment after surgery for ductal carcinoma i...
Dr Mila Donker - Netherlands Cancer Institute, Amsterdam
15-year follow-up on radiotherapy treatment after surgery for ductal carcinoma in situ ( Dr Mila Donker - Netherlands Cancer Institute, Amsterdam )
2 Apr 2012
Need for updated breast cancer guidelines and screening programs
Prof Marco Rosselli del Turco - President of the European Society of Breast Canc...
Need for updated breast cancer guidelines and screening programs ( Prof Marco Rosselli del Turco - President of the European Society of Breast Cancer Specialists (EUSOMA) )
30 Mar 2012
FLIMS workshop and management of triple negative breast cancer
Dr Margaret Hutka - Royal Marsden Hospital, London, UK
FLIMS workshop and management of triple negative breast cancer  ( Dr Margaret Hutka - Royal Marsden Hospital, London, UK )
30 Mar 2012
Debate on breast cancer screening contributing to drop in mortality
Prof Fiona Gilbert - University of Cambridge, UK
Debate on breast cancer screening contributing to drop in mortality ( Prof Fiona Gilbert - University of Cambridge, UK )
30 Mar 2012
Triple negative advanced breast cancer treatment with PARP inhibitors
Dr Tim Yap - Royal Marsden Hospital, London, UK
Triple negative advanced breast cancer treatment with PARP inhibitors ( Dr Tim Yap - Royal Marsden Hospital, London, UK )
30 Mar 2012
Highlights from EBCC 8 and looking to EBCC 9
Prof David Cameron - University of Edinburgh, UK
Highlights from EBCC 8 and looking to EBCC 9 ( Prof David Cameron - University of Edinburgh, UK )
29 Mar 2012
ECCO and cancer care in Europe
Prof Cornelis van de Velde - President of ECCO
ECCO and cancer care in Europe ( Prof Cornelis van de Velde - President of ECCO )
29 Mar 2012
Managing the toxicity of aromatase inhibitors
Dr Patrick Neven - Leuven University, Belgium
Managing the toxicity of aromatase inhibitors ( Dr Patrick Neven - Leuven University, Belgium )
29 Mar 2012
New technology for identifying and removing micro metastases in breast cancer pa...
Prof Michael Douek - Guy's and St. Thomas Hospitals, London, UK
New technology for identifying and removing micro metastases in breast cancer patients ( Prof Michael Douek - Guy's and St. Thomas Hospitals, London, UK )
29 Mar 2012
Managing HER2 overexpression in breast cancer
Prof Michael Untch - Helios Clinic, Berlin, Germany
Managing HER2 overexpression in breast cancer ( Prof Michael Untch - Helios Clinic, Berlin, Germany )
29 Mar 2012
Debate on the success of breast cancer screening programmes
Prof Richard Peto - Clinical Trial Service Unit, Oxford University, UK
Debate on the success of breast cancer screening programmes ( Prof Richard Peto - Clinical Trial Service Unit, Oxford University, UK )
24 Mar 2012
Analysis of thirty years of clinical trial data
Prof Richard Peto - Clinical Trial Service Unit, Oxford University, UK
Analysis of thirty years of clinical trial data ( Prof Richard Peto - Clinical Trial Service Unit, Oxford University, UK )
23 Mar 2012
Cost of MRI screening for women with a family history of breast cancer
Dr Sepideh Saadatmand - Erasmus University Medical Center, Rotterdam, Netherland...
Cost of MRI screening for women with a family history of breast cancer ( Dr Sepideh Saadatmand - Erasmus University Medical Center, Rotterdam, Netherlands )
22 Mar 2012
Effectiveness of breast cancer screening
Rianne de Gelder - Erasmus University Medical Center, Rotterdam, Netherlands
Effectiveness of breast cancer screening ( Rianne de Gelder - Erasmus University Medical Center, Rotterdam, Netherlands )
22 Mar 2012
Results from national breast cancer screening programme
Jacques Fracheboud - Erasmus University Medical Center, Rotterdam, Netherlands
Results from national breast cancer screening programme ( Jacques Fracheboud - Erasmus University Medical Center, Rotterdam, Netherlands )
22 Mar 2012